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http://dx.doi.org/10.1016/j.kjms.201Abstract Although the central autonomic network (CAN) has been well researched in animal
models, the CAN in humans is still unclear, especially for cardiovascular control. This study
aimed to investigate which areas of the cerebral cortices are associated with the peripheral
cardiac autonomic control involved in the CAN in uremic patients with autonomic dysfunction
and normal controls. The central and peripheral autonomic network in 19 uremic patients with
significant autonomic dysfunction and 24 age- and sex-matched controls [mean age  standard
deviation (SD), 55.16  10.45 years and 55.42  5.42 years, respectively] were evaluated by
simultaneous spectral analysis of electroencephalography (EEG) and electrocardiography
recording (ECG), along with serial autonomic tests [autonomic questionnaire and orthostatic
blood pressure (BP) change]. Only frequency-domain heart rate variability (f-HRV) during
the deep-breathing stage could differentiate the two groups. Although there is no significanthave no conflicts of interest relevant to this article.
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126 L.-M. Liou et al.difference in f-HRV during the quiet-breathing stage, different patterns of central oscillation
and their correlation with peripheral cardiac autonomic indices could be found for the two
groups. Although the power of specific EEG bands under electrode T3 and T6 correlated signif-
icantly with the power of peripheral HRV indices in the control group, those under electrodes
P3 and Pz had significant correlations in the uremic group suggesting a role of functional con-
nectivity between them. In addition, sympathetic activity is correlated with slow wave EEG
(theta/delta) power whereas parasympathetic activity is correlated with fast wave EEG (beta)
power. In conclusion, there is functional connectivity between the parietal cortex and the pe-
ripheral cardiac autonomic system (PAN) in uremics and the pattern of central autonomic con-
nectivity differs between uremic patients with autonomic dysfunction and normal controls.
Copyright ª 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Through the purported central autonomic network (CAN),
the brain can significantly affect autonomic outflow and
manage afferenteefferent integration of the autonomic
nervous system [1]. The neuroanatomy of the CAN has been
well described in animal models: afferent autonomic inflow
is carried via cranial, sacral, and thoracolumbar nervous
pathways to the nucleus in the medulla, pons, thalamus,
and subsequently hypothalamus, amygdala, or insula.
Efferent autonomic outflow, which are mainly from the
medulla, can also be modulated by both afferent auto-
nomic inflow and central command from a set of regions
including the rostral ventromedial medulla, midbrain peri-
aqueductal gray, hypothalamus, amygdala, and dorsome-
dial prefrontal and anterior cingulate cortices [1].
Although the medulla oblongata is regarded as the pri-
mary cardiac autonomic center, recent animal studies have
highlighted that certain cerebral cortices, such as insular
cortex and anterior cingulate cortex, the amygdala, and
the cerebellum are involved with the modulation of car-
diovascular control [2]. However, studies on connectivity
between the CAN and the peripheral cardiac autonomic
system (PAN) in humans were still limited. One author re-
ported that electrical stimulation of the insular cortex,
anterior cingulate cortex, and medial temporal lobe leads
to changes in blood pressure (BP) and heart rate (HR) giving
clues that there is effective connectivity between certain
cerebral cortices and the PAN [2]. Napadow et al. [1] used a
combined functional magnetic resonance imaging (fMRI)
and heart rate variability (HRV) method to investigate the
connectivity between the CAN and the PAN in humans.
They reported that powers of high frequency (HF) corre-
lates with fMRI activity in the hypothalamus, cerebellum,
parabrachial nucleus/locus ceruleus, periaqueductal gray,
amygdala, hippocampus, thalamus, and dorsomedial/
dorsolateral prefrontal, posterior insular, and middle tem-
poral cortices indicating that there is functional connec-
tivity between the CAN and the PAN. Although some regions
are consistent with those in animal models, other mostly
higher cortical or limbic-related brain regions may be
unique to humans [1]. However, this type of research is
expensive and a special cardiac-gated fMRI technique is
essential.
Since 1960, some electroencephalography (EEG) studies
have found that there are connections between brainactivity and the PAN [3]. In 2005, Takahashi et al. [4] also
found that there are correlations between changes in EEG
band power and frequency-domain HRV (f-HRV) indices
during meditation. Because f-HRV represents PAN function,
the brain areas that have significant correlation between
quantitative EEG power and f-HRV indices (central link
pattern) may represent their CAN and its link to the PAN.
Autonomic dysfunction is an important issue in uremic pa-
tients [5] because it occurs in 66% of uremic patients and is
regarded as one of the possible mechanisms of increased
cardiovascular mortality [6,7]. However, the CAN in ure-
mics with autonomic dysfunction and its connection to the
PAN is not clear. We hypothesized that there is functional
connectivity between the cerebral cortex and the PAN in
uremics and that the pattern of central autonomic con-
nectivity differs between uremic patients with autonomic
dysfunction and controls. In the literature, most simulta-
neous spectral analysis of EEG and ECG studies used only a
small number of electrodes to study brain activity. There
are no studies focusing on uremic patients. The present
study aimed to assess which cerebral cortices are associ-
ated with the PAN in uremic patients and healthy controls.Patients and methods
Participants
Participants were consecutively recruited from Kaohsiung
Municipal Hsiao-Kang Hospital, Kaohsiung, Taiwan. The
uremic group consisted of 19 participants [mean
age  standard deviation (SD), 55.16  10.45 years; female-
to-male ratio: 9/10] with regular bicarbonate hemodialysis
(for 4 hours thrice weekly). Patients with conditions known
to affect cardiac and peripheral sensorimotor functions,
such as diabetes mellitus, amyloidosis or alcoholism, his-
tory of arrhythmia, severe heart failure, ischemic heart
disease, or broncho-pneumopathy were excluded. Patients
with central nervous system diseases, such as Parkinson’s
disease and cerebrovascular disease were also excluded.
None of the patients were taking medications acting on the
autonomic nervous system, including beta-blockers, ben-
zodiazepines, etc.
Twenty-four age- and sex-matched controls (mean
age  SD, 55.42  5.42 years; female-to-male ratio: 18/6)
were recruited from the hospital and local community.
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or disease treatment affecting peripheral sensorimotor and
autonomic functions. All participants in both groups un-
derwent an assessment of autonomic function and simul-
taneous EEG and ECG recordings after signed informed
consent was given.
Each participant was asked to refrain from smoking and
drinking coffee for at least 12 hours, and not to exercise for
24 hours prior to the experiment, and to refrain from eating
and drinking for at least 3 hours prior to the examination.
The examinations were performed during the same time
period of the day (from 10 AM to 12 PM). The uremics were
examined on a dialysis-free day. The patients were initially
asked to complete an autonomic questionnaire, which
included two items related to the cardiovascular system:
palpitations and orthostatic dizziness. The answer to each
item was either “Yes” or “No”. They were then instructed
to lie in the supine position on a bed in a quiet and elec-
trically shielded room with the temperature around 25 C.
They were asked to be relaxed and think about nothing.
After 10 minutes, a bedside cardiovascular reflex test for
orthostatic systolic BP change was performed [8]. The test
of predominantly sympathetic function was BP response to
active standing. After completing the test, each participant
had a 10-minute rest in the supine position.
EEG and ECG electrodes were then attached and simul-
taneous recordings were performed. Each participant was
asked to perform two stages: closed eyes with quiet
breathing for 5 minutes, followed by deep breathing for
another 5 minutes. After another 2 minutes, the examina-
tion was complete. The local institutional review board
approved all study protocols.Simultaneous EEG and ECG recording and analysis
The EEG activity was recorded using nineteen electrodes
(Fp1, Fp2, Fz, F3, F4, F7, F8, Cz, C3, C4, Pz, P3, P4, T3, T4,
T5, T6, O1, and O2) according to the International 10-20
System, referenced to linked ear lobe electrodes. The EEG
activity was recorded using a Nicolet monitor (Alliance 226,
Nicolet; Madison, Wisconsin, USA) digitized at 1024 Hz with a
low filter at 1 Hz and high filter at 70 Hz (decay constant
12 dB). Impedance was less than 10 kV for each electrode.
EEG signals (sampling frequency, 500 Hz) were recordedwith
a time constant of 0.1 second and a sensitivity of 7 mV/mm.
The data were simultaneously stored on a magnetic optical
disk for offline analysis.
Two ECG electrodes were placed on either side of the
heart in front of the chest to record the electrical activity
of the heart over time. The EEG and ECG recordings were
made simultaneously.
The Matlab software (version 7.12) was used to detect
and analyze the EEG and ECG channels. In the EEG chan-
nels, artifacts due to eyeball, body movements, swallow-
ing, and drowsiness were excluded from the analysis. The
power spectrum of delta (0.3e4 Hz), theta (4e8 Hz), alpha
(8e13 Hz), and beta (13e30 Hz) bands during approxi-
mately 5 minutes of quiet breathing and 5 minutes of deep
breathing were then obtained by Fast Fourier trans-
formation. The power spectrum of alpha, beta, theta, and
delta were then transferred to alpha percentage (alphapower/total power), beta percentage (beta power/total
power), theta percentage (theta power/total power), and
delta percentage (delta power/total power) to decrease
the influence of the small difference in analysis time.
In the ECG channel, the recording time was a constant
for 5 minutes. We used the method designed by Lin et al.
[9] to analyze HRV. The QRS complexes were detected and
labeled automatically. The results of the automatic analysis
were reviewed subsequently and any errors in R-wave
detection and QRS labeling were then edited manually. HRV
was assessed automatically by the monitor from the
calculation of the mean ReR interval and its SD measured
on consecutive 5 minutes ECG. Normal-to-normal ReR in-
terval data obtained from the edited time sequence of R-
wave and QRS labeling were then transferred to a personal
computer.
There were two ways to express LF (low frequency) and
HF (high frequency): absolute values (ms2) and relative
values (normalized units: LF nu and HF nu). After Fast
Fourier transformation, the frequency-domain parameters
selected were LF (power spectrum between 0.04 Hz and
0.15 Hz), HF (power spectrum between 0.15 Hz and
0.40 Hz), and VLF (very low frequency; power spectrum
below 0.04 Hz). The LF and HF components were obtained
in absolute values of power (ms2). The values of LF nu and
HF nu, which represented the relative value of the power of
each component in proportion to the total power minus the
VLF component, were then obtained. Normalized units
tended to minimize the effect of the change in total power
on the values of LF and HF components, and could better
provide the balance and integration of sympathetic and
parasympathetic modulation. These parameters were
defined in accordance with the 1996 the American College
of Cardiology (ACC)/the American Heart Association (AHA)/
the European Society of Cardiology (ESC) consensus [10]. In
line with this, the LF nu and HF nu were chosen as pa-
rameters to find the balance of sympathetic and para-
sympathetic modulation and the correlation with the
percentage of alpha, beta, theta, and delta EEG power,
respectively.Statistical analysis
Statistical analyses were conducted using the JMP soft-
ware for Windows (version 8.02). The power spectrum
values were expressed as mean  SD. Statistical compar-
isons of the results were made using the Student t test.
When comparing symptoms suggestive of autonomic
dysfunction, baseline HR, orthostatic BP change, quiet-
breathing and deep-breathing LF nu and HF nu between
the uremic and control groups, significance levels were set
at p < 0.05. When comparing percentage of alpha, beta,
theta, and delta EEG power between the uremic and
control groups in quiet-breathing and deep-breathing, we
used the Bonferroni strategy of multiple comparisons (19
EEG electrodes) to Type I error rate of significant factors
by dividing 0.05 by 19, and significance levels were set at
p < 0.00263. The association between the percent change
of EEG power and HRV indices was analyzed using a
multivariate regression test with repeated measurements
on percentage of alpha, beta, theta, and delta EEG power,
Table 2 Electrodes with significant differences in alpha,
beta, theta, and delta electroencephalography (EEG) power
on the International 10-20 System during quiet- and deep-
breathing stages.
Quiet-breathing stage Deep-breathing stage
Electrode p Electrode p
Alphaa F3 0.0017 F4 0.0026
Cz 0.0005 Cz <0.0001
C3 0.0009 C3 <0.0001
C4 0.0007 C4 <0.0001
T3 0.0024 T3 0.0018
d d Pz 0.0007
d d P3 0.0007
Betaa d d d d
Thetaa d d d d
Deltaa F3 0.0024 F4 0.0026
Cz 0.0004 Cz <0.0001
C3 0.0013 C3 0.0005
C4 0.0002 C4 0.0003
Pz 0.0002 P3 <0.0001
P3 0.0001 P4 0.0003
Pz <0.0001
a ByStudent t test,Bonferroni strategyofmultiple comparisons.
128 L.-M. Liou et al.and LF nu and HF nu. Unless otherwise specified, signifi-
cance was set at p < 0.05.
Results
Autonomic questionnaire between uremic and
control groups
The uremic group showed significantly more symptoms
of orthostatic dizziness (p Z 0.00007) and palpitations
(p Z 0.0024) compared to the control group, indicating
autonomic dysfunction (Table 1).
Differences in f-HRV indices between the uremic
and control groups during quiet- and deep-
breathing stages
By means of f-HRV and using LF nu and HF nu as parameters,
there were no significant differences in LF nu and HF nu
between the two groups during the quiet-breathing stage
(pZ 0.1031; Table 1). However, during the deep-breathing
stage, the uremic group had significantly higher HF nu
(lower LF nu; p Z 0.0014).
Electrodes with significant differences in
percentage of alpha, beta, theta, and delta EEG
power on the International 10-20 System during
quiet- and deep-breathing stages
The percentage of alpha, beta, theta, and delta EEG power
at different electrodes between the two groups during
quiet- and deep-breathing stages were compared (Table 2).
During the quiet-breathing stage, the uremic group had a
significantly lower percentage of alpha EEG power at the
F3, Cz, C3, C4, and T3 electrodes (pZ 0.0017, pZ 0.0005,
p Z 0.0009, p Z 0.0007, and p Z 0.0024, respectively)Table 1 Demographic data, clinical characteristics, heart rate
ratio in the uremic and control groups.
Uremics (n Z 1
Mean  SD
Agea (y) 55.16  10.45
Sexb (male/female) 10/9
Palpitationb 11
Orthostatic dizzinessb 12
Baseline heart ratea (beats/min) 73.05  2.37
Orthostatic SBP changea 12.00  17.84
Quiet-breathing stage
LF nua 43.33  25.97
HF nua 56.67  25.97
Deep-breathing stage
LF nua 73.30  25.26
HF nua 26.70  25.26
HF nuZ normalized unit of high frequency power; LF nuZ normalize
SBP Z systolic blood pressure; SD Z standard deviation.
The values that appear in bold font indicates p < 0.05.
a Student t test.
b c2 test.compared to the control group. The uremic group had a
significantly higher percentage of delta EEG power at the
F3, Cz, C3, C4, Pz, and P3 electrodes (p Z 0.0024,
p Z 0.0004, p Z 0.0013, p Z 0.0002, p Z 0.0002, and
p Z 0.0001, respectively) compared to the control group.
During the deep-breathing stage, the uremic group had a
significantly lower percentage of alpha EEG power at the
F4, Cz, C3, C4, T3, Pz, and P3 electrodes (p Z 0.0026,
p < 0.0001, p < 0.0001, p < 0.0001, p Z 0.0018,
p Z 0.0007, and p Z 0.0007, respectively). The uremic
group had a significantly higher percentage of delta EEGvariability (HRV) indices, and central sympathetic correlation
9) Control (n Z 24) p
Mean  SD
55.42  5.42 0.92
6/18 0.062
4 0.0024
2 0.00007
66.71  2.11 0.052
8.00  8.51 0.338
55.28  22.17 0.1031
44.73  22.17 0.1031
91.25  4.89 0.0014
8.75  4.89 0.0014
d unit of low frequency power; RRIVZ variability of RR interval;
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Central autonomic network in uremics 129power at the F4, Cz, C3, C4, P3, P4, and Pz electrodes
(p Z 0.0026, p < 0.0001, p Z 0.0005, p Z 0.0003,
p < 0.0001, p Z 0.0003, and p < 0.0001, respectively).
Compared to the quiet-breathing stage, there are rela-
tive higher percentages of alpha and beta EEG power and
relatively lower percentages of theta and delta EEG power
both in control and uremic groups during the deep-
breathing stage. However, there is no significant differ-
ence (Table 2).Electrodes with significant correlation between
power of LF nu (sympathetic activity) and HF nu
(parasympathetic activity) and percentage of
alpha, beta, theta, and delta EEG power
Multivariate regression analysis was used to test the rela-
tionship between the percentage of alpha, beta, theta, and
delta EEG power and HRV indices with repeated measure-
ments. In the quiet-breathing stage, in the control group,
there were significantly positive correlations between LF nu
(negative correlations between HF nu) and percentage
of theta EEG power at the T3 (p Z 0.0316) and T6
(p Z 0.0467) electrodes. In the uremic group, there were
significantly positive correlations between LF nu (negative
correlations between HF nu) and percentage of delta EEG
power at the P3 (p Z 0.0236) and Pz (p Z 0.0112) elec-
trodes and positive correlations between HF nu (negative
correlations between LF nu) and percentage of beta EEG
power at the Pz (p Z 0.0206) electrode (Table 3).
In the deep-breathing stage, in the control group, there
were significantly positive correlations between the LF nu
(negative correlations between the HF nu) and percentage of
theta EEG power at the T4 (p Z 0.034) electrode. In the
uremic group, there were significantly positive correlations
between HF nu (negative correlations between LF nu) and
percentage of beta EEG power at the C3, C4, F7, and F8
(p Z 0.020, p Z 0.016, p Z 0.019, and p Z 0.015, respec-
tively) electrodes; significantly positive correlationsbetween
LF nu (negative correlations between HF nu) and percentage
of alpha EEG power at the Fz (pZ 0.023) electrode (Table 3).
When LF nu was used as sympathetic modulation and HF
nu as parasympathetic modulation [11], local EEG power
under electrodes that have correlations with power of LF nu
or HF nu were regarded as brain areas having central
sympathetic or parasympathetic modulations (CAN). These
are shown in Table 3.
In summary, during the quiet-breathing stage, while the
power of specific EEG bands under electrodes T3
(p Z 0.0316) and T6 (p Z 0.0467; temporal cortex) had
significant correlation with the power of peripheral HRV
indices in the control group (Fig. 1A), those under elec-
trodes P3 (p Z 0.0236) and Pz (p Z 0.0112; extratemporal
cortex) had significant correlation with the power of pe-
ripheral HRV indices in the uremic group (Fig. 1B). During
the deep-breathing stage, while the power of specific EEG
bands under electrodes T4 (p Z 0.034) had significant
correlation with the power of peripheral HRV indices in the
control group (Fig. 1C), those under electrodes C3, C4, F7,
F8, and Fz (p Z 0.020, 0.016, 0.019, 0.015, and 0.023,
respectively) had significant correlation with the power of
peripheral HRV indices in the uremic group (Fig. 1D).
Figure 1. During the quiet-breathing stage, (A) there were significant correlations between HRV indices and specific EEG band
power at the T3 and T6 electrodes in the control group; (B) significant correlations between HRV indices and specific EEG band
power at the Pz and P3 electrodes in the uremic group. During the deep-breathing stage, (C) there were significant correlations
between HRV indices and specific EEG band power at the T4 electrodes in the control group; (D) significant correlations between
HRV indices and specific EEG band power at the C3, C4, Fz, F7, and F8 electrodes in the uremic group.
EEG Z electroencephalography; HRV Z heart rate variability.
130 L.-M. Liou et al.Discussion
The present study demonstrates functional connectivity
between the parietal cortex and the PAN in uremics and the
pattern of central autonomic connectivity differs between
uremic patients and healthy controls. Although HRV indices
cannot differentiate uremic patients from controls during
the quiet-breathing stage, different patterns of central
connectivity between these two groups can be observed.
This is the first study to investigate the integration of the
CAN and the PAN by means of spectral analysis of simulta-
neous EEG and ECG recordings in uremic patients.
The role of the cerebral cortex in the modulation of
autonomic function becomes more and more important
because long-term potentiation can be induced in the
human brain by the technique of transcranial magnetic
stimulation [12]. The quantitative EEG is used to investigate
the activity of the cerebral cortex because of its better
temporal resolution from variable electrophysiological and
hemodynamic methods. It can help for diagnosis and pre-
dict prognosis in clinical settings, such as Alzheimer’s dis-
ease [13,14]. In our study, during the quiet-breathing stage,
there were significantly positive correlations between LF nuand percentage of theta EEG power in the control group,
whereas there were significantly positive correlations be-
tween LF nu and percentage of delta EEG power and be-
tween HF nu and percentage of beta EEG power in the
uremic group. Sympathetic activity (LF nu) seems to
correlate with slow wave EEG power: theta in control, and
delta in uremics. These results are similar as in some animal
studies [15,16]. Parasympathetic activity (HF nu) seems to
correlate with fast wave EEG power: beta in uremics. No
similar results have been reported previously for this. The
significance of alpha, beta, theta, and delta rhythm are
different in various physiological conditions. For example,
although alpha waves are generally related to the condition
of “relaxed wakefulness”, frontocentral alpha waves can
possibly reflect sleep-maintaining processes [17]. Although
theta waves are prominent in non-rapid eye movement
(NREM) sleep [18], frontal theta rhythm is related to the
meditation state [4]. Whether parasympathetic or sympa-
thetic impairment is prominent in uremic patients remains
controversial [19]: although some authors favor more
sympathetic impairment [20], others favor more para-
sympathetic damage or both [19]. These may be due to
different methodologies. The uremics in our study had
Central autonomic network in uremics 131significantly lower LF nu than the control group during the
deep-breathing stage (Table 1), suggesting more sympa-
thetic impairment in uremic patients.
The “deep-breathing” test is used because it is actually
an effective autonomic challenge test for differentiating
pathologic conditions, such as differentiating Parkinson’s
disease (PD) from multiple system atrophy (MSA) patients
[21]. This may explain why there were only significant dif-
ferences in the HRV indices during deep-breathing stages in
our study, although more orthostatic dizziness and palpita-
tions were found in the uremic group (p< 0.05). In our study,
we found that the deep-breathing maneuver changed the
power of HRV indices significantly, whereas it did not change
EEG power. These may explain why the cerebral cortices
that are functionally connected with the cardiac autonomic
system differ between quiet- and deep-breathing stages.
The CAN is complex. In recent years, there has been
increasing evidence supporting the role of frontal, temporal,
and parietal cerebral cortex [22] in the CAN of humans. For
example, infarctions involving the parietal lobe seem to be
associated with a particularly increased risk of cardiac events
and death [23]. Lateralization, lesion size-specific, and
disease-specificity [23e26] are also important issues in the
CAN. Autonomic responses of lateralized lesions have been
shown to be opposite between stroke and epileptic patients
[24,25]. In stroke patients the left prefrontal cortex lesions
result in decreased cardiovascular responses to visual
emotional stimuli [25],whereas inepilepsypatientsduringthe
Wada test, left-hemispheric inactivation increases sympa-
thetic cardiovascular modulation [24]. Min et al. [26] further
demonstrated that left focal insular ischemia that induced
cardiac dysfunction was related to the extent of insular
cortical injury. These factors may explain why P3 and Pz are
involved in the CAN in uremics with autonomic dysfunction.
The capacity of the nervous system to reorganize
(plasticity) is of fundamental importance for recovery from
brain injury [27]. In Parkinson’s disease patients, to facili-
tate complex finger movements, there is a switch from the
use of the striato-mesial frontal to the parietal-lateral
premotor circuits [28]. The present study shows similar
results in uremic patients with autonomic dysfunction.
There is a switch from the use of temporal areas (T3, T6) to
parietal areas (P3, Pz) in the uremics with autonomic
dysfunction (Fig. 1).
This study has some limitations. First, the EEG has no
accurate anatomical specificity due to the filter function of
the skull. However, its strength lies in the superior tem-
poral discrimination and it can detect functional connec-
tivity of brain activity and HRV. Electrocorticography
(ECoG) can provide more accurate EEG power but is an
invasive technique inappropriate for routine clinical use.
Multimodal neuroimaging studies combining EEG and im-
aging could provide a possible way to resolve this problem
in future studies [29]. Second, like Ako et al.’s method [18],
we correlated data from pairs of 5-minute HRV indices and
EEG spectral power. Because these are not real-time
physiological results, the temporal relationship between
EEG and HRV may be compromised. However, a 5-minute f-
HRV recording is essential in the diagnosis and quantifica-
tion of dysfunction in the PAN [20]. At least we can say
there is correlation between EEG and HRV during the same
5-minute time period.In conclusion, there is functional connectivity between
the parietal cortex and the PAN in uremics and the pattern
of central autonomic connectivity differs between uremic
patients with autonomic dysfunction and normal controls.
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